Dr. Mary Claire Haver

And most of it is preventable.

And even the calculators, the cardiovascular risk calculators don't take into account menopause in the right way.

They consider you being on HRT a risk of cardiovascular disease when that has never been proven true in a younger patient who was given menopause hormone therapy close to her menopause.

We have so much work to do in how we diagnose, how we evaluate, how we treat.

I had Dr. Andrea Matsumura on, sleep medicine specialist, the screening tool for sleep apnea.

For women, they don't get a point.

If you're female, you don't get a point.

We have sleep apnea.

And so we are missing these diseases that have only really been evaluated in men with many of our screening terms.

So if you're not taught to see something in school, in our training, we have a lot to learn.

And so much of what we do is great.

You don't look for it.

So if these screening tools are not really evaluating a woman and taking into account the hormone changes that are wreaking havoc throughout her body, we are going to miss ways that we could help women.

And when you don't look for it, women are going to suffer.

Okay, so what can we do about it?

I have to refer to my notes because I get really impassioned here.

We have to empower through evidence.

We need to fund the studies.

And the way we fund studies in this country are through two main ways, okay, or three.

The National Institutes of Health, and we are undergoing a massive transition in how we fund studies looking at that institution.